Related Experiment Video
Updated: Apr 15, 2026

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
Inflammasome inhibition: putting out the fire
Mihai G Netea1, Leo A B Joosten1
1Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
New inhibitors target the NLRP3 inflammasome, blocking caspase-1 activation and reducing inflammatory cytokine release. These specific compounds offer a promising targeted approach for managing NLRP3-driven inflammation.
Area of Science:
- Immunology
- Molecular Biology
Background:
- The NLRP3 inflammasome is a key mediator of inflammatory responses.
- It activates caspase-1, processing pro-inflammatory cytokines like IL-1β and IL-18.
Purpose of the Study:
- To review recent advancements in NLRP3 inflammasome inhibition.
- To highlight the potential of specific inhibitors for treating inflammatory conditions.
Main Methods:
- Review of recent scientific literature on NLRP3 inflammasome inhibitors.
- Analysis of compound specificity and potency data.
Main Results:
- Identification of specific NLRP3 inflammasome inhibitors.
- Demonstration of these inhibitors' ability to block IL-1β release and inflammation.
Conclusions:
- Specific NLRP3 inflammasome inhibitors show significant promise.
- Targeted inhibition offers a potential therapeutic strategy for NLRP3-driven inflammation.
Related Concept Videos
The JAK-STAT Signaling Pathway
Inhibitors of Viral Protein Synthesis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Caspases

